EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $758,000 | -34.2% | 9,608 | -30.8% | 0.03% | -39.3% |
| Q1 2017 | $1,152,000 | +59.8% | 13,892 | +52.9% | 0.06% | -3.4% |
| Q4 2016 | $721,000 | +235.3% | 9,083 | +274.9% | 0.06% | +286.7% |
| Q4 2015 | $215,000 | -43.4% | 2,423 | -52.8% | 0.02% | -34.8% |
| Q3 2015 | $380,000 | -47.0% | 5,138 | -42.0% | 0.02% | -42.5% |
| Q2 2015 | $717,000 | +116.6% | 8,862 | +12.2% | 0.04% | +100.0% |
| Q1 2015 | $331,000 | – | 7,896 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |